Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Non-cash Items (2016 - 2025)

Enanta Pharmaceuticals filings provide 14 years of Non-cash Items readings, the most recent being $16.9 million for Q4 2025.

  • On a quarterly basis, Non-cash Items changed N/A to $16.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.9 million, a N/A change, with the full-year FY2025 number at $6.5 million, up 356.0% from a year prior.
  • Non-cash Items hit $16.9 million in Q4 2025 for Enanta Pharmaceuticals, up from $6.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $97.2 million in Q4 2021 to a low of $2000.0 in Q2 2023.
  • Median Non-cash Items over the past 5 years was $8.4 million (2023), compared with a mean of $20.4 million.
  • Biggest five-year swings in Non-cash Items: crashed 99.99% in 2023 and later surged 161350.0% in 2024.
  • Enanta Pharmaceuticals' Non-cash Items stood at $97.2 million in 2021, then plummeted by 81.84% to $17.6 million in 2022, then tumbled by 82.84% to $3.0 million in 2023, then plummeted by 53.24% to $1.4 million in 2024, then soared by 1095.83% to $16.9 million in 2025.
  • The last three reported values for Non-cash Items were $16.9 million (Q4 2025), $6.5 million (Q3 2025), and $92000.0 (Q2 2025) per Business Quant data.